Le Lézard
Classified in: Health
Subjects: SVY, PET, ANW

Global Veterinary Diagnostic Testing for Pets and Animals Will Grow to $5.8 Billion in 2027


"The World Market for Veterinary Diagnostics, 6th Edition" is the latest market research report from Kalorama Information.

ARLINGTON, Va., Feb. 23, 2023 /PRNewswire-PRWeb/ -- Where the pets go, so go the profits. This is true not just for mainstream pet products (such as food and toys) or services (such as grooming and boarding), but extends to veterinary pet healthcare, most notably veterinary diagnostic testing. Indeed, the global veterinary diagnostic market is forecast to grow to approximately $5.8 billion in 2027, according to The World Market for Veterinary Diagnostics, 6th Edition, the latest report by market research firm Kalorama Information.

The veterinary diagnostics market is best characterized preliminarily through its two primary segments: companion animal (pets such as dogs and cats and domestic animals including horses) and food animal (livestock and production animal) diagnostics. The two segments differ significantly in terms of demand, drivers and primary product groups. Infectious disease is a significant component in the veterinary care of companion animals, though improving standards and levels of consumer spending on companion animal care produce a much larger market for laboratory analyzers used for non-infectious disease or general health testing. Food animal diagnostics is led foremost by infectious disease assays in various forms described in this section.

"Diagnostic testing is an important aspect of animal healthcare. There is a wide variety of tests available for veterinarians to use to identify and monitor diseases," says Bruce Carlson, publisher for Kalorama Information.

Veterinary diagnostic testing is becoming more mainstream as consumers embrace advanced pet healthcare. Diagnostic testing has become more sophisticated in the last several years benefiting from advancements in technology and accuracy. Testing has become a mainstay in the practice of veterinary medicine and has proven to be vital for the safety of food animals and well-being of companion animals. In vitro diagnostic (IVD) instrumentation and products have been extensively applied to veterinary healthcare; various assay forms, analytes and analyzers are transferrable from the clinical space to the veterinary clinic and laboratory.

Veterinary diagnostics comprehensively support animal health:

International trade, public health, agricultural productivity, consumer confidence and companion animal-owner relationships are all dependent upon effective and increasingly specialized veterinary diagnostics products. Expertise in molecular diagnostics, virology and bacteriology is crucial in the food animal (livestock and production animal) diagnostics space as emergent threats and outbreaks necessitate the development and improvement of assays for newly implemented disease control programs. Technical barriers to entry in the lucrative companion animal diagnostics space are relatively low. Many market participants in companion animal diagnostics have adapted clinical diagnostic analyzers?hematology analyzers or blood counters, chemistry analyzers, critical care analyzers?with modifications limited mostly to reference ranges, sample preparation and some parameters.

PURCHASE THE REPORT

The World Market for Veterinary Diagnostics, 6th Edition examines the worldwide veterinary diagnostics market through the performance of its two component markets of companion animal (pets) and food animal diagnostics. The report provides analysis of major veterinary disease markets as well as overall market performance and development.

For more information or to purchase the market research report "The World Market for Veterinary Diagnostics, 6th Edition," visit: https://kaloramainformation.com/product/veterinary-diagnostics-dogs-cats-horses-pets/.

ABOUT KALORAMA INFORMATION

Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals. Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry-leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Kalorama Information produces 30 reports a year. The firm offers a Knowledge Center, which provides access to all published reports.

Media Contact

DANIEL GRANDERSON, Kalorama Information, (703) 783-1721, [email protected]

 

SOURCE Kalorama Information


These press releases may also interest you

at 03:30
Alchemab Therapeutics (Alchemab), an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, today announces the publication of a peer reviewed article titled "Predictability of B cell clonal...

at 03:00
Viewpoint, a national educational program hosted by renowned actor Dennis Quaid, will be shooting an episode with Maine-based behavioral health organization, Sweetser. The upcoming episode, scheduled to film on May 30th, will focus on addressing the...

at 02:59
International medical imaging IT and cybersecurity company Sectra's (STO: SECT B) enterprise imaging solution has been selected by the university hospital Hospital Universidad del Norte, in Colombia. As part of their journey to unify medical imaging...

at 02:38
Today, Tuesday 14 May, starting at 13:30 CEST, ASSA ABLOY hosts its Capital Markets Day in Prague, Czech Republic, where Nico Delvaux, President & CEO and Erik Pieder, CFO, will provide an update on ASSA ABLOY's strategy and direction. This will...

at 02:38
Allied Market Research published a report, titled, "Biometric Payment Market by Type (Contact-Based, Contactless, Hybrid), Biometric Mode (Fingerprint Recognition, Facial Recognition, Voice Recognition, Iris Scans, Others), and...

at 02:26
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, welcomes a new hospital performing the RefluxStoptm procedure in Italy, Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone. In late...



News published on and distributed by: